Tehran University of Medical Sciences Acta Medica Iranica 0044-6025 43 2 2005 04 15 95 98 A. Mohammadzadeh F. Naseri 2015 09 28 Recombinant human erythropoietin (rh-EPO) is known to accelerate erythropoiesis in preterm infants. The purpose of this study was to compare the effectiveness of early treatment with two doses of rh-EPO (high vs. low dose) in the management of anemia of prematurity. Twenty preterm infants with hematocrit (Hct) < 30% when infant’s age was between 2 to 3 weeks after birth or Hct https://acta.tums.ac.ir/index.php/acta/article/view/2971 https://acta.tums.ac.ir/index.php/acta/article/download/2971/2952